Current treatments of diabetic macular edema

International Journal of Gerontology

Volumn 5, Issue 4, 2011, Pages 183-188

  Chan, Wei Chun ^a   Tsai, Shawn H ^a   Wu, Ai Ching ^a   Chen, Lee Jen ^a   Lai, Chi Chun ^b  

^a MACKAY MEMORIAL HOSPITAL   (Taiwan)

^b CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

Author keywords

bevacizumab; diabetes mellitus; laser; macular edema; ranibizumab

Indexed keywords

BEVACIZUMAB; CORTICOSTEROID; DEXAMETHASONE; FLUOCINOLONE ACETONIDE; HISTAMINE; PEGAPTANIB; PLACEBO; PROTEIN KINASE C; RANIBIZUMAB; RUBOXISTAURIN; TRIAMCINOLONE ACETONIDE; VASCULOTROPIN; VASCULOTROPIN ANTIBODY;

CATARACT EXTRACTION; CHOROID DETACHMENT; DATA BASE; DIABETES MELLITUS; DIABETIC MACULAR EDEMA; DIABETIC RETINOPATHY; DRUG EFFICACY; EPIRETINAL MEMBRANE; FIBRINOID SYNDROME; GLAUCOMA; HUMAN; LASER COAGULATION; MACULAR ISCHEMIA; MEDLINE; MONOTHERAPY; NEOVASCULAR GLAUCOMA; NONPROLIFERATIVE DIABETIC RETINOPATHY; OPTICAL COHERENCE TOMOGRAPHY; PATHOGENESIS; PIGMENT EPITHELIUM; PRIORITY JOURNAL; RETINA DETACHMENT; RETINA FLUORESCEIN ANGIOGRAPHY; RETINA MACULA AGE RELATED DEGENERATION; RETINA MACULA LUTEA; RETINA TEAR; REVIEW; TREATMENT OUTCOME; VISION; VISUAL IMPAIRMENT; VITRECTOMY; VITREOUS HEMORRHAGE;

EID: 84862779165     PISSN: 18739598     EISSN: 1873958X     Source Type: Journal    
DOI: 10.1016/j.ijge.2011.09.013     Document Type: Review

References (52)

1. World Health Organization. Diabetes Fact Sheet No 312 Jan 2011. Available from: http://www.who.int/whr/en/ [accessed 02.11].
2. C.H. Chang, W.Y. Shau, and Y.D. Jiang Type 2 diabetes prevalence and incidence among adults in Taiwan during 1999-2004: a national health insurance data set study Diabet Med 27 2010 636 643
3. N. Bhagat, R.A. Grigorian, and A. Tutela Diabetic macular edema: pathogenesis and treatment Surv Ophthalmol 54 2009 1 32
4. R. Klein, B.E. Klein, and S.E. Moss The Wisconsin epidemiologic study of diabetic retinopathy IV. Diabetic macular edema Ophthalmology 91 1984 1464 1474 (Pubitemid 15197017)
5. C.H. Meyer Current treatment approaches in diabetic macular edema Ophthalmologica 221 2007 118 131 (Pubitemid 46465437)
6. Early Treatment Diabetic Retinopathy Study Research Group Photocoagulation for diabetic macular edema. Early Treatment Diabetic Retinopathy Study report number 1 Arch Ophthalmol 103 1985 1796 1806
7. C.M. Lee, and R.J. Olk Modified grid laser photocoagulation for diffuse diabetic macular edema. Long-term visual results Ophthalmology 98 1991 1594 1602
8. A.J. Barkmeier, B.P. Nicholson, and L. Akduman Effectiveness of laser photocoagulation in clinically significant macular edema with focal versus diffuse parafoveal thickening on optical coherence tomography Ophthalmic Surg Lasers Imaging 40 2009 472 479
9. H. Schatz, D. Madeira, and H.R. McDonald Progressive enlargement of laser scars following grid laser photocoagulation for diffuse diabetic macular edema Arch Ophthalmol 109 1991 1549 1551
10. B.K. Rutledge, I.H. Wallow, and G.L. Poulsen Sub-pigment epithelial membranes after photocoagulation for diabetic macular edema Arch Ophthalmol 111 1993 608 613 (Pubitemid 23143164)
11. Diabetic Retinopathy Clinical Research Network A Randomized Trial of Peribulbar Triamcinolone Acetonide with and without Focal Photocoagulation for Mild Diabetic Macular Edema: a Pilot Study Ophthalmology 114 2007 1190 1196
12. M. Entezari, H. Ahmadieh, and M.H. Dehghan Posterior sub-tenon triamcinolone for refractory diabetic macular edema: A randomized clinical trial Eur J Ophthalmol 15 2005 746 750 (Pubitemid 43074701)
13. L.K. Verma, M.B. Vivek, and A. Kumar A prospective controlled trial to evaluate the adjunctive role of posterior subtenon triamcinolone in the treatment of diffuse diabetic macular edema J Ocul Pharmacol Ther 20 2004 277 284 (Pubitemid 39108892)
14. M. Shimura, T. Nakazawa, and K. Yasuda Pretreatment of posterior subtenon injection of triamcinolone acetonide has beneficial effects for grid pattern photocoagulation against diffuse diabetic macular oedema Br J Ophthalmol 91 2007 449 454 (Pubitemid 46623675)
15. M. Tunc, H.I. Onder, and M. Kaya Posterior sub-Tenon's capsule triamcinolone injection combined with focal laser photocoagulation for diabetic macular edema Ophthalmology 112 2005 1086 1091 (Pubitemid 40797466)
16. Diabetic Retinopathy Clinical Research Network A randomized trial comparing intravitreal triamcinolone acetonide and focal grid photocoagulation for diabetic macular edema Ophthalmology 115 2008 1447 1459
17. F.K.P. Sutter, J.M. Simpson, and M.C. Gillies Intravitreal triamcinolone for diabetic macular edema that persists after laser treatment: three-month efficacy and safety results of a prospective, randomized, double-masked, placebo-controlled clinical trial Ophthalmology 111 2004 2044 2049 (Pubitemid 39446723)
18. O.O. Maia Jr., B.S. Takahashi, and R.A. Costa Combined laser and intravitreal triamcinolone for proliferative diabetic retinopathy and macular edema: one-year results of a randomized clinical trial Am J Ophthalmol 147 2009 291 297
19. B. Kaderli, R. Avci, and O. Gelisken Intravitreal triamcinolone as an adjunct in the treatment of concomitant proliferative diabetic retinopathy and diffuse diabetic macular oedema. Combined IVTA and laser treatment for PDR with CSMO Int Ophthalmol 26 2005 207 214 (Pubitemid 46415832)
20. A. Mirshahi, H. Shenazandi, and A. Lashay Intravitreal triamcinolone as an adjunct to standard laser therapy in coexisting high-risk proliferative diabetic retinopathy and clinically significant macular edema Retina 30 2010 254 259
21. D.S. Lam, C.K. Chan, and S. Mohamed Intravitreal triamcinolone plus sequential grid laser versus triamcinolone or laser alone for treating diabetic macular edema: six-month outcomes Ophthalmology 114 2007 2162 2167
22. T. Yilmaz, C.D. Weaver, and M.J. Gallagher Intravitreal triamcinolone acetonide injection for treatment of refractory diabetic macular edema: A systematic review Ophthalmology 116 2009 902 913
23. J.A. Haller, B.D. Kuppermann, and M.S. Blumenkranz Randomized controlled trial of an intravitreous dexamethasone drug delivery system in patients with diabetic macular edema Arch Ophthalmol 128 2010 289 296
24. B.D. Kuppermann, M.S. Blumenkranz, and J.A. Haller Randomized controlled study of an intravitreous dexamethasone drug delivery system in patients with persistent macular edema Arch Ophthalmol 125 2007 309 317 (Pubitemid 46425557)
25. P.A. Campochiaro, G. Hafiz, and S.M. Shah Sustained ocular delivery of fluocinolone acetonide by an intravitreal insert Ophthalmology 117 2010 1393 1399
26. X.L. Yang, K. Liu, and X. Xu Update on treatments of diabetic macular edema Chin Med J 122 2009 2784 2790
27. L.P. Aiello, S.-E. Bursell, and A. Clermont Vascular endothelial growth factor-induced retinal permeability is mediated by protein kinase C in vivo and suppressed by an orally effective beta isoform selective inhibitor Diabetes 46 1997 1473 1480 (Pubitemid 27369086)
28. PKC-DMES Study Group Effect of ruboxistaurin in patients with diabetic macular edema: thirty-month results of the randomized PKC-DMES clinical trial Arch Ophthalmol 125 2007 318 324
29. PKC-DRS Study Group The effect of ruboxistaurin on visual loss in patients with moderately severe to very severe nonproliferative diabetic retinopathy: initial results of the protein kinase C beta Inhibitor diabetic retinopathy study (PKC-DRS) multicenter randomized clinical trial Diabetes 54 2005 2188 2197
30. M.D. Davis, M.J. Sheetz, and L.P. Aiello Effect of ruboxistaurin on the visual acuity decline associated with long-standing diabetic macular edema Invest Ophthalmol Vis Sci 50 2009 1 4
31. E.T. Cunningham Jr., A.P. Adamis, and M. Altaweel A phase II randomized double-masked trial of pegaptanib, an anti-vascular endothelial growth factor aptamer, for diabetic macular edema Ophthalmology 112 2005 1747 1757
32. G. Querques, A.V. Bux, and A.R. Fusco Pegaptanib sodium versus pegaptanib sodium combined with macular laser photocoagulation or laser alone for diabetic macular edema J Ophthalmol 2009 2009 672178
33. Q.D. Nguyen, S.M. Shah, and J.S. Heier Primary end point (six months) results of the Ranibizumab for Edema of the mAcula in diabetes (READ-2) study Ophthalmology 116 2009 2175 2181
34. Q.D. Nguyen, S.M. Shah, and A.A. Khwaja Two-year outcomes of the ranibizumab for edema of the mAcula in diabetes (READ-2) study Ophthalmology 117 2010 2146 2151
35. P. Massin, F. Bandello, and J.G. Garweg Safety and efficacy of ranibizumab in diabetic macular edema (RESOLVE Study): a 12-month, randomized, controlled, double-masked, multicenter phase II study Diabetes Care 33 2010 2399 2405
36. Diabetic Retinopathy Clinical Research Network, M.J. Elman, L.P. Aiello, and R.W. Beck Randomized trial evaluating ranibizumab plus prompt or deferred laser or triamcinolone plus prompt laser for diabetic macular edema Ophthalmology 117 2010 1064 1077
37. J.F. Arevalo, J.G. Sanchez, and L. Wu Primary intravitreal bevacizumab for diffuse diabetic macular edema: the Pan-American collaborative retina study group at 24 months Ophthalmology 116 2009 1488 1497
38. D.S. Lam, T.Y. Lai, and V.Y. Lee Efficacy of 1.25 MG versus 2.5 MG intravitreal bevacizumab for diabetic macular edema: six-month results of a randomized controlled trial Retina 29 2009 292 299
39. M. Michaelides, A. Kaines, and R.D. Hamilton A prospective randomized trial of intravitreal bevacizumab or laser therapy in the management of diabetic macular edema (BOLT study) 12-month data: report 2 Ophthalmology 117 2010 1078 1086
40. K.A. Solaiman, M.M. Diab, and M. Abo-Elenin Intravitreal bevacizumab and/or macular photocoagulation as a primary treatment for diffuse diabetic macular edema Retina 30 2010 1638 1645
41. M. Soheilian, A. Ramezani, and A. Obudi Randomized trial of intravitreal bevacizumab alone or combined with triamcinolone versus macular photocoagulation in diabetic macular edema Ophthalmology 116 2009 1142 1150
42. H. Faghihi, R. Roohipoor, and S.F. Mohammadi Intravitreal bevacizumab versus combined bevacizumab-triamcinolone versus macular laser photocoagulation in diabetic macular edema Eur J Ophthalmol 18 2008 941 948
43. M. Soheilian, A. Ramezani, and B. Bijanzadeh Intravitreal bevacizumab (avastin) injection alone or combined with triamcinolone versus macular photocoagulation as primary treatment of diabetic macular edema Retina 27 2007 1187 1195 (Pubitemid 350211523)
44. H. Ahmadieh, A. Ramezani, and N. Shoeibi Intravitreal bevacizumab with or without triamcinolone for refractory diabetic macular edema; a placebo-controlled, randomized clinical trial Graefes Arch Clin Exp Ophthalmol 246 2008 483 489 (Pubitemid 351447960)
45. T. Otani, and S. Kishi A controlled study of vitrectomy for diabetic macular edema Am J Ophthalmol 134 2002 214 219 (Pubitemid 34831825)
46. U. Stolba, S. Binder, and D. Gruber Vitrectomy for persistent diffuse diabetic macular edema Am J Ophthalmol 140 2005 295 301
47. Diabetic Retinopathy Clinical Research Network Writing Committee, J.A. Haller, H. Qin, and R.S. Apte Vitrectomy outcomes in eyes with diabetic macular edema and vitreomacular traction Ophthalmology 117 2010 1087 1093
48. J.I. Patel, P.G. Hykin, and M. Schadt Diabetic macular oedema: pilot randomised trial of pars plana vitrectomy vs macular argon photocoagulation Eye (Lond) 20 2006 873 881 (Pubitemid 44210178)
49. M. Bahadir, A. Ertan, and O. Mertolu Visual acuity comparison of vitrectomy with and without internal limiting membrane removal in the treatment of diabetic macular edema Int Ophthalmol 26 2005 3 8
50. M.L. Laursen, F. Moeller, and B. Sander Subthreshold micropulse diode laser treatment in diabetic macular oedema Br J Ophthalmol 88 2004 1173 1179 (Pubitemid 39141379)
51. J. Figueira, J. Khan, and S. Nunes Prospective randomised controlled trial comparing sub-threshold micropulse diode laser photocoagulation and conventional green laser for clinically significant diabetic macular oedema Br J Ophthalmol 93 2009 1341 1344
52. S. Vujosevic, E. Bottega, and M. Casciano Microperimetry and fundus autofluorescence in diabetic macular edema: subthreshold micropulse diode laser versus modified early treatment diabetic retinopathy study laser photocoagulation Retina 30 2010 908 916